[{"address1": "1800 Sierra Point Parkway", "address2": "Suite 200", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "650 484 0899", "website": "https://dayonebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.", "fullTimeEmployees": 181, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jeremy  Bender M.B.A., Ph.D.", "age": 53, "title": "CEO, President & Director", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 1195600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Charles N. York II, M.B.A.", "age": 47, "title": "COO & CFO", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 854200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adam  Dubow J.D.", "age": 57, "title": "General Counsel, Chief Compliance Officer & Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 692700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Stubenrauch Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jaa  Roberson", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Davy  Chiodin Ph.D., Pharm.D.", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lauren  Merendino M.B.A.", "age": 48, "title": "Chief Commercial Officer", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Elly  Barry M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael J. Vasconcelles M.D., Ph.D.", "age": 61, "title": "Head of Research & Development", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.71, "open": 6.65, "dayLow": 6.425, "dayHigh": 6.72, "regularMarketPreviousClose": 6.71, "regularMarketOpen": 6.65, "regularMarketDayLow": 6.425, "regularMarketDayHigh": 6.72, "payoutRatio": 0.0, "beta": -1.272, "forwardPE": -5.9375, "volume": 1027898, "regularMarketVolume": 1027898, "averageVolume": 1405141, "averageVolume10days": 1313980, "averageDailyVolume10Day": 1313980, "bid": 6.62, "ask": 6.67, "bidSize": 4, "askSize": 3, "marketCap": 674057280, "fiftyTwoWeekLow": 6.08, "fiftyTwoWeekHigh": 16.76, "priceToSalesTrailing12Months": 4.162852, "fiftyDayAverage": 6.686, "twoHundredDayAverage": 9.975925, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 203956416, "profitMargins": -0.42663, "floatShares": 71940998, "sharesOutstanding": 101362000, "sharesShort": 10280741, "sharesShortPriorMonth": 12608785, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.1014, "heldPercentInsiders": 0.17046, "heldPercentInstitutions": 0.94538003, "shortRatio": 7.69, "shortPercentOfFloat": 0.1509, "impliedSharesOutstanding": 101362000, "bookValue": 4.731, "priceToBook": 1.4056225, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -69080000, "trailingEps": -0.65, "forwardEps": -1.12, "enterpriseToRevenue": 1.26, "enterpriseToEbitda": -1.078, "52WeekChange": -0.4984917, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 6.65, "targetHighPrice": 36.0, "targetLowPrice": 18.0, "targetMeanPrice": 26.25, "targetMedianPrice": 27.0, "recommendationMean": 1.55556, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 473020000, "totalCashPerShare": 4.667, "ebitda": -189212000, "totalDebt": 2916000, "quickRatio": 10.257, "currentRatio": 10.624, "totalRevenue": 161922000, "debtToEquity": 0.608, "revenuePerShare": 1.665, "returnOnAssets": -0.27812, "returnOnEquity": -0.17797, "grossProfits": 153759008, "freeCashflow": -155793248, "operatingCashflow": -87381000, "grossMargins": 0.94958997, "ebitdaMargins": -1.16854, "operatingMargins": -1.3350301, "financialCurrency": "USD", "symbol": "DAWN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1754090425, "regularMarketTime": 1754078401, "exchange": "NMS", "messageBoardId": "finmb_704589075", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.894187, "regularMarketPrice": 6.65, "fiftyDayAverageChange": -0.035999775, "fiftyDayAverageChangePercent": -0.0053843516, "twoHundredDayAverageChange": -3.3259254, "twoHundredDayAverageChangePercent": -0.33339518, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-05-27", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1622122200000, "postMarketChangePercent": 0.451124, "postMarketPrice": 6.68, "postMarketChange": 0.0299997, "regularMarketChange": -0.0599999, "regularMarketDayRange": "6.425 - 6.72", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1405141, "fiftyTwoWeekLowChange": 0.5700002, "fiftyTwoWeekLowChangePercent": 0.09375003, "fiftyTwoWeekRange": "6.08 - 16.76", "fiftyTwoWeekHighChange": -10.110001, "fiftyTwoWeekHighChangePercent": -0.603222, "fiftyTwoWeekChangePercent": -49.84917, "earningsTimestamp": 1754424000, "earningsTimestampStart": 1754424000, "earningsTimestampEnd": 1754424000, "earningsCallTimestampStart": 1754425800, "earningsCallTimestampEnd": 1754425800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.65, "epsForward": -1.12, "epsCurrentYear": -1.3452, "priceEpsCurrentYear": -4.943503, "shortName": "Day One Biopharmaceuticals, Inc", "longName": "Day One Biopharmaceuticals, Inc.", "marketState": "CLOSED", "displayName": "Day One Biopharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]